27304 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 27
13:44 UTC
|
ANF
Abercrombie & Fitch
|
◎ Target | Alex Straton not yet tracked | Equal Weight | $87.00→ $134.00+54.0% |
|
Aug 27
13:44 UTC
|
ANF
Abercrombie & Fitch
|
◎ Target | Dana Telsey ★★☆☆☆ #2241 | Outperform | $118.00→ $165.00+39.8% |
|
Aug 27
12:45 UTC
|
SLDB
Solid Biosciences
|
◎ Target | Kristen Kluska ★☆☆☆☆ #2918 | Overweight | $16.00→ $26.00+62.5% |
|
Aug 27
12:45 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Robert Burns ★★☆☆☆ #2613 | Buy | $195.00→ $280.00+43.6% |
|
Aug 27
12:45 UTC
|
P
Everpure
|
◎ Target | Mike Cikos ★★★★★ #24 | Buy | $100.00→ $140.00+40.0% |
|
Aug 27
12:45 UTC
|
OKTA
Okta
|
◎ Target | Jonathan Ruykhaver ★★★★★ #142 | Overweight | $170.00→ $200.00+17.6% |
|
Aug 27
12:45 UTC
|
OKTA
Okta
|
◎ Target | Gray Powell ★★★★★ #16 | Buy | $167.00→ $187.00+12.0% |
|
Aug 27
12:45 UTC
|
OKTA
Okta
|
◎ Target | Mike Cikos ★★★★★ #24 | Buy | $140.00→ $200.00+42.9% |
|
Aug 27
12:45 UTC
|
NVDA
NVIDIA
|
◎ Target | N. Quinn Bolton not yet tracked | Buy | $270.00→ $300.00+11.1% |
|
Aug 27
12:45 UTC
|
NTNX
Nutanix
|
◎ Target | Mike Cikos ★★★★★ #24 | Buy | $60.00→ $85.00+41.7% |
|
Aug 27
12:45 UTC
|
MDT
Medtronic
|
◎ Target | Mike Matson not yet tracked | Buy | $101.00→ $114.00+12.9% |
|
Aug 27
12:45 UTC
|
DY
Dycom Industries
|
◎ Target | Manish A. Somaiya not yet tracked | Overweight | $654.00→ $476.00-27.2% |
|
Aug 27
12:45 UTC
|
CRM
Salesforce
|
◎ Target | Brian White ★★★★★ #295 | Buy | $222.00→ $266.00+19.8% |
|
Aug 27
12:45 UTC
|
BFST
Business First Bancshares
|
◎ Target | Feddie Strickland ★★★★☆ #495 | Outperform | $36.00→ $37.00+2.8% |
|
Aug 27
12:45 UTC
|
AMRC
Ameresco
|
◎ Target | Manish A. Somaiya not yet tracked | Overweight | $44.00→ $36.00-18.2% |
|
Aug 27
09:45 UTC
|
ONT
Oxford Nanopore Technologies
|
◎ Target | firm only | Overweight | GBX 190→ GBX 220+15.8% |
|
Aug 27
09:45 UTC
|
DNLM
Dunelm Group
|
◎ Target | firm only | Buy | GBX 1,332→ GBX 1,200-9.9% |
|
Aug 27
09:45 UTC
|
ASC
ASOS
|
◎ Target | firm only | Buy | GBX 420→ GBX 520+23.8% |
|
Aug 27
00:44 UTC
|
ZYME
Zymeworks
|
◎ Target | Yigal Nochomovitz ★★☆☆☆ #2288 | Buy | $37.00→ $38.00+2.7% |
|
Aug 27
00:44 UTC
|
ZYME
Zymeworks
|
◎ Target | Robert Burns ★★☆☆☆ #2613 | Buy | $51.00→ $55.00+7.8% |
|
Aug 27
00:44 UTC
|
ZS
Zscaler
|
◎ Target | Brian Essex ★★★☆☆ #962 | Overweight | $205.00→ $215.00+4.9% |
|
Aug 27
00:44 UTC
|
ZM
Zoom Communications
|
◎ Target | Meta Marshall ★★★★☆ #441 | Equal Weight | $105.00→ $107.00+1.9% |
|
Aug 27
00:44 UTC
|
ZM
Zoom Communications
|
◎ Target | Samad Samana ★★★★☆ #452 | Buy | $118.00→ $116.00-1.7% |
|
Aug 27
00:44 UTC
|
WTB
Whitbread
|
◎ Target | firm only | Hold | GBX 2,050→ GBX 2,250+9.8% |
|
Aug 27
00:44 UTC
|
WT
WisdomTree
|
◎ Target | Chris Kotowski ★★★★☆ #598 | Outperform | $22.00→ $27.00+22.7% |
|
Aug 27
00:44 UTC
|
VMRK
Vivmark Residential Common Shares of Beneficial Interest
|
◎ Target | Alexander Goldfarb ★★★☆☆ #1692 | Neutral | $75.00→ $76.00+1.3% |
|
Aug 27
00:44 UTC
|
UGP
Ultrapar Participacoes
|
◎ Target | Bruno Amorim ★★★☆☆ #987 | Neutral | $6.50→ $5.80-10.8% |
|
Aug 27
00:44 UTC
|
TECK.B
Teck Resources
|
◎ Target | firm only | Outperform | C$93.00→ C$105.00+12.9% |
|
Aug 27
00:44 UTC
|
SYRE
Spyre Therapeutics
|
◎ Target | David Hoang ★★★☆☆ #2201 | Buy | $135.00→ $127.00-5.9% |
|
Aug 27
00:44 UTC
|
SYRE
Spyre Therapeutics
|
◎ Target | Julian Harrison ★☆☆☆☆ #2906 | Buy | $132.00→ $121.00-8.3% |
|
Aug 27
00:44 UTC
|
SYRE
Spyre Therapeutics
|
◎ Target | David Nierengarten ★★★☆☆ #1768 | Outperform | $130.00→ $123.00-5.4% |
|
Aug 27
00:44 UTC
|
SNOW
Snowflake
|
◎ Target | Tyler Radke ★★★★☆ #461 | Buy | $320.00→ $395.00+23.4% |
|
Aug 27
00:44 UTC
|
SMTC
Semtech
|
◎ Target | Timothy Arcuri ★★★★☆ #841 | Buy | $225.00→ $230.00+2.2% |
|
Aug 27
00:44 UTC
|
SMTC
Semtech
|
◎ Target | Joseph Moore ★★★☆☆ #1217 | Equal Weight | $175.00→ $195.00+11.4% |
|
Aug 27
00:44 UTC
|
SMPL
Simply Good Foods
|
◎ Target | Robert Moskow ★★★☆☆ #1072 | Hold | $13.00→ $11.00-15.4% |
|
Aug 27
00:44 UTC
|
REPL
Replimune Group
|
◎ Target | Anupam Rama ★☆☆☆☆ #2948 | Overweight | $20.00→ $21.00+5.0% |
|
Aug 27
00:44 UTC
|
RBRK
Rubrik
|
◎ Target | Blair Abernethy ★★★★☆ #497 | Buy | $95.00→ $105.00+10.5% |
|
Aug 27
00:44 UTC
|
QUBT
Quantum Computing
|
◎ Target | Edward Woo ★☆☆☆☆ #3079 | Buy | $30.00→ $32.00+6.7% |
|
Aug 27
00:44 UTC
|
PSTL
Postal Realty Trust
|
◎ Target | Anthony Paolone ★★★☆☆ #1829 | Neutral | $23.00→ $25.00+8.7% |
|
Aug 27
00:44 UTC
|
OLLI
Ollie's Bargain Outlet
|
◎ Target | Steven Zaccone ★★★☆☆ #1597 | Buy | $111.00→ $100.00-9.9% |
|
Aug 27
00:44 UTC
|
NTSK
Netskope
|
◎ Target | Brian Essex ★★★☆☆ #962 | Overweight | $14.00→ $16.00+14.3% |
|
Aug 27
00:44 UTC
|
NI
NiSource
|
◎ Target | Gabriel Moreen not yet tracked | Outperform | $50.00→ $48.00-4.0% |
|
Aug 27
00:44 UTC
|
NCNO
nCino
|
◎ Target | Ryan Tomasello ★★★★☆ #677 | Outperform | $24.00→ $25.00+4.2% |
|
Aug 27
00:44 UTC
|
NCNO
nCino
|
◎ Target | James Faucette ★★★☆☆ #1453 | Overweight | $23.00→ $25.00+8.7% |
|
Aug 27
00:44 UTC
|
NCNO
nCino
|
◎ Target | Saket Kalia ★★★★★ #101 | Overweight | $22.00→ $23.00+4.5% |
|
Aug 27
00:44 UTC
|
NCNO
nCino
|
◎ Target | Aaron Kimson ★★★☆☆ #1503 | Market Outperform | $23.00→ $25.00+8.7% |
|
Aug 27
00:44 UTC
|
NCNO
nCino
|
◎ Target | Terry Tillman ★★★★☆ #848 | Hold | $19.00→ $20.00+5.3% |
|
Aug 27
00:44 UTC
|
MZTI
Marzetti
|
◎ Target | Brian Holland ★☆☆☆☆ #2884 | Neutral | $168.00→ $130.00-22.6% |
|
Aug 27
00:44 UTC
|
MDB
MongoDB
|
◎ Target | Rudy Kessinger ★★★★★ #71 | Buy | $375.00→ $465.00+24.0% |
|
Aug 27
00:44 UTC
|
MDB
MongoDB
|
◎ Target | Raimo Lenschow ★★★★☆ #538 | Overweight | $387.00→ $460.00+18.9% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.